| 44543-7 |
Human papilloma virus 31+33 Ag |
PrThr |
XXX |
Pt |
Ord |
|
|
ACTIVE |
Human papilloma virus 31+33 Ag [Presence] in Specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44543-7 |
|
|
|
|
Both |
|
|
|
0 |
HPV31+33 Ag Spec Ql |
|
|
|
N |
|
Antigen; Antigens; Genital warts; HPV; HPV31; HPV31+33; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Papilloma virus high risk; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44544-5 |
Human papilloma virus 35 Ag |
PrThr |
XXX |
Pt |
Ord |
|
|
ACTIVE |
Human papilloma virus 35 Ag [Presence] in Specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44544-5 |
|
|
|
|
Both |
|
|
|
0 |
HPV35 Ag Spec Ql |
|
|
|
N |
|
Antigen; Antigens; Genital warts; HPV; HPV35; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified |
2.69 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44545-2 |
Human papilloma virus DNA |
PrThr |
Urethra |
Pt |
Ord |
Probe |
|
ACTIVE |
Human papilloma virus DNA [Presence] in Urethra by Probe |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44545-2 |
|
Probe |
|
|
Both |
|
|
|
0 |
HPV DNA Urth Ql Probe |
|
|
|
N |
|
Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; HPV; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Urth |
2.63 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44546-0 |
Human papilloma virus DNA |
PrThr |
Vag |
Pt |
Ord |
Probe |
|
ACTIVE |
Human papilloma virus DNA [Presence] in Vaginal fluid by Probe |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44546-0 |
|
Probe |
|
|
Both |
|
|
|
0 |
HPV DNA Vag Ql Probe |
|
|
|
N |
|
Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Genital warts; Gyn; Gynecology; HPV; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Vag fld; Vag fluid; Vagina; Vaginal fluid |
2.63 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44547-8 |
Human papilloma virus DNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.sig |
|
ACTIVE |
Human papilloma virus DNA [Presence] in Specimen by Probe with signal amplification |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44547-8 |
|
Probe.amp.sig |
|
|
Both |
|
|
|
0 |
HPV DNA Spec Ql Probe+sig amp |
|
|
|
N |
|
Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HC; HPA; HPV; Human papillomavirus; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; UniversalLabOrders; Unspecified |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44548-6 |
Human papilloma virus DNA |
PrThr |
Urethra |
Pt |
Ord |
Probe.amp.sig |
|
ACTIVE |
Human papilloma virus DNA [Presence] in Urethra by Probe with signal amplification |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44548-6 |
|
Probe.amp.sig |
|
|
Both |
|
|
|
0 |
HPV DNA Urth Ql Probe+sig amp |
|
|
|
N |
|
Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; HC; HPA; HPV; Human papillomavirus; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen; Urth |
2.63 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44549-4 |
Human papilloma virus DNA |
PrThr |
Vag |
Pt |
Ord |
Probe.amp.sig |
|
ACTIVE |
Human papilloma virus DNA [Presence] in Vaginal fluid by Probe with signal amplification |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44549-4 |
|
Probe.amp.sig |
|
|
Both |
|
|
|
0 |
HPV DNA Vag Ql Probe+sig amp |
|
|
|
N |
|
Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Genital warts; Gyn; Gynecology; HC; HPA; HPV; Human papillomavirus; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen; Vag fld; Vag fluid; Vagina; Vaginal fluid |
2.63 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 4455-2 |
Trimethoprim |
Mass |
Dose |
Pt |
Qn |
|
|
ACTIVE |
Trimethoprim [Mass] of Dose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUGDOSE |
|
4455-2 |
|
|
|
|
Observation |
|
|
|
0 |
Trimethoprim Dose |
|
|
|
Y |
|
c202; c242; C62; Dose med or substance; DRUG DOSES; Point in time; Polytrim; Primsol; Proloprim; QNT; Quan; Quant; Quantitative; Random; TMP; Trimeth; Trimpex |
2.69 |
1 |
|
|
|
|
|
|
|
mg |
|
|
|
0 |
| 44550-2 |
Human papilloma virus DNA |
PrThr |
Cvx |
Pt |
Ord |
Probe |
|
ACTIVE |
Human papilloma virus DNA [Presence] in Cervix by Probe |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44550-2 |
|
Probe |
|
|
Both |
|
|
|
0 |
HPV DNA Cvx Ql Probe |
|
|
|
N |
|
Cervix; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; Gyn; Gynecology; HPV; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44551-0 |
Human papilloma virus DNA |
PrThr |
Tiss |
Pt |
Ord |
Probe |
|
ACTIVE |
Human papilloma virus DNA [Presence] in Tissue by Probe |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44551-0 |
|
Probe |
|
|
Both |
|
|
|
0 |
HPV DNA Tiss Ql Probe |
|
|
|
N |
|
Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44552-8 |
hydroCHLOROthiazide |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
hydroCHLOROthiazide [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
44552-8 |
|
|
|
|
Both |
|
|
|
0 |
HTCZ SerPl Ql |
|
|
|
N |
|
Aldactizide; c381; DRUG/TOXICOLOGY; Drugs; Esidrix; HCTZ; HTCZ; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44553-6 |
Hydroxyitraconazole |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Hydroxyitraconazole [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
44553-6 |
|
|
|
|
Both |
|
|
|
0 |
OH-Itraconaz SerPl Ql |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Hydroxy itraconazole; Itraconazole metabolite; OH-Itraconaz; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44554-4 |
Hymenopterase Ab.IgE.RAST class |
PrThr |
Ser |
Pt |
Ord |
|
|
DEPRECATED |
Deprecated Hymenopterase IgE Ab RAST class [Presence] in Serum |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
44554-4 |
|
|
|
|
Observation |
|
|
|
0 |
Deprecated Hymenopterase IgE RAST Ql |
|
|
|
N |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; IgE RAST; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.65 |
2.17 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 44555-1 |
Immunoglobulin light chains.kappa.free |
PrThr |
Ser |
Pt |
Ord |
Immunofixation |
|
ACTIVE |
Kappa light chains.free [Presence] in Serum by Immunofixation |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
44555-1 |
|
Immunofixation |
|
|
Observation |
|
|
|
0 |
Kappa LC Free Ser Ql IFE |
|
|
|
N |
|
Bence Jones protein; BJ Protein; BJP; Chain; Chemistry; FR; Hematology; Heme; IFE; Ifix; Immune globulin; Immuno; Immunofixation electrophoresis; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Kappa LC; Kappa LC Free; Non-protein bound; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. Changed the LCN from 'Immunoglobulin light chains.kappa.free' to ' Kappa light chains.free' for readability. |
0 |
| 44556-9 |
Influenza virus A Ab |
PrThr |
Ser |
Pt |
Ord |
Comp fix |
|
ACTIVE |
Influenza virus A Ab [Presence] in Serum by Complement fixation |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44556-9 |
|
Comp fix |
|
|
Both |
|
|
|
0 |
FLUAV Ab Ser Ql CF |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian influenza; Bird flu; CF; Comp fixation; Compfix; Complement fixation; FLUA; FLUAV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44557-7 |
Influenza virus A Ab |
PrThr |
Body fld |
Pt |
Ord |
|
|
ACTIVE |
Influenza virus A Ab [Presence] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44557-7 |
|
|
|
|
Both |
|
|
|
0 |
FLUAV Ab Fld Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian influenza; B/F; BF; Bird flu; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; FLUA; FLUAV; Fluid; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44558-5 |
Influenza virus A Ag |
PrThr |
Nph |
Pt |
Ord |
IF |
|
ACTIVE |
Influenza virus A Ag [Presence] in Nasopharynx by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44558-5 |
|
IF |
|
|
Both |
|
|
|
0 |
FLUAV Ag Nph Ql IF |
|
|
|
N |
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Avian influenza; Bird flu; DFA; FA; FLUA; FLUAV; Fluorescent antibody; Fluoresent; FLUV; Fowl plague; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Microbiology; Nasopharynx; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; TRF |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44559-3 |
Influenza virus A Ag |
PrThr |
Bronchial |
Pt |
Ord |
IF |
|
ACTIVE |
Influenza virus A Ag [Presence] in Bronchial specimen by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44559-3 |
|
IF |
|
|
Both |
|
|
|
0 |
FLUAV Ag Bronch Ql IF |
|
|
|
N |
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Avian influenza; Bird flu; Bro; DFA; FA; FLUA; FLUAV; Fluorescent antibody; Fluoresent; FLUV; Fowl plague; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Lung; Microbiology; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Time Resolved Fluorescence; TRF |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 4456-0 |
Trimipramine |
Mass |
Dose |
Pt |
Qn |
|
|
ACTIVE |
Trimipramine [Mass] of Dose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUGDOSE |
|
4456-0 |
|
|
|
|
Observation |
|
|
|
0 |
Trimipramine Dose |
|
|
|
Y |
|
Addiction; Cotrimazine; Dose med or substance; DRUG DOSES; Drugs of abuse; Illicit; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Surmontil; TMP |
2.69 |
1 |
|
|
|
|
|
|
|
mg |
|
|
|
0 |
| 44560-1 |
Influenza virus A Ag |
PrThr |
Nose |
Pt |
Ord |
IF |
|
ACTIVE |
Influenza virus A Ag [Presence] in Nose by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44560-1 |
|
IF |
|
|
Both |
|
|
|
0 |
FLUAV Ag Nose Ql IF |
|
|
|
N |
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Avian influenza; Bird flu; DFA; FA; FLUA; FLUAV; Fluorescent antibody; Fluoresent; FLUV; Fowl plague; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Microbiology; Nasal; Nos; Nose (nasal passage); Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Smell; Time Resolved Fluorescence; TRF |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44561-9 |
Influenza virus A Ag |
PrThr |
Trac |
Pt |
Ord |
IF |
|
ACTIVE |
Influenza virus A Ag [Presence] in Trachea by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44561-9 |
|
IF |
|
|
Both |
|
|
|
0 |
FLUAV Ag Trachea Ql IF |
|
|
|
N |
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Avian influenza; Bird flu; DFA; FA; FLUA; FLUAV; Fluorescent antibody; Fluoresent; FLUV; Fowl plague; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Trachea; TRF |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44562-7 |
Influenza virus A Ag |
PrThr |
Bronchial |
Pt |
Ord |
|
|
ACTIVE |
Influenza virus A Ag [Presence] in Bronchial specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44562-7 |
|
|
|
|
Both |
|
|
|
0 |
FLUAV Ag Bronch Ql |
|
|
|
N |
|
Antigen; Antigens; Avian influenza; Bird flu; Bro; FLUA; FLUAV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Lung; Microbiology; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44563-5 |
Influenza virus A Ag |
PrThr |
Nose |
Pt |
Ord |
|
|
ACTIVE |
Influenza virus A Ag [Presence] in Nose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44563-5 |
|
|
|
|
Both |
|
|
|
0 |
FLUAV Ag Nose Ql |
|
|
|
N |
|
Antigen; Antigens; Avian influenza; Bird flu; FLUA; FLUAV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Microbiology; Nasal; Nos; Nose (nasal passage); Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Smell |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44564-3 |
Influenza virus A Ag |
PrThr |
Nose |
Pt |
Ord |
IA |
|
ACTIVE |
Influenza virus A Ag [Presence] in Nose by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44564-3 |
|
IA |
|
|
Both |
|
|
|
0 |
FLUAV Ag Nose Ql IA |
|
|
|
N |
|
Antigen; Antigens; Avian influenza; Bird flu; EIA; ELFA; ELISA; Enzyme immunoassay; FLUA; FLUAV; FLUV; Fowl plague; IAA; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; MEIA; Microbiology; Nasal; Nos; Nose (nasal passage); Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Smell; SUDS |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 44565-0 |
Influenza virus A+B Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Influenza virus A+B Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
44565-0 |
|
|
|
|
Both |
|
|
|
0 |
FLUAV+FLUBV Ab Ser Ql |
|
|
|
N |
|
A,B; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian influenza; Bird flu; FLUA; FLUAV; FLUAV + FLUBV; FLUAV+FLUBV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.56 |
2.17 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
